Freedom Capital Markets Maintains Buy on Enovis, Lowers Price Target to $36

Benzinga Newsdesk www.benzinga.com Negative 47.8%

Neg 47.8% Neu 0% Pos 0%

Freedom Capital Markets analyst Keith Hinton maintains Enovis (NYSE:ENOV) with a Buy and lowers the price target from $41 to $36.